Relative potency of oral transmucosal fentanyl citrate (OTFC) in comparison with intravenous (IV) morphine (MSO4) in the treatment of post operative pain.

被引：0
|
作者：
Ginsberg, B
Sevarino, F
Joshi, G
Lichtor, L
Philip, B
机构：
[1] DUKE UNIV,DURHAM,NC 27706
[2] YALE UNIV,NEW HAVEN,CT 06520
[3] UNIV CHICAGO,CHICAGO,IL 60637
[4] BRIGHAM & WOMENS HOSP,BOSTON,MA 02115
来源：
ANESTHESIOLOGY | 1997年 / 87卷 / 03期
关键词：
D O I：
10.1097/00000542-199709001-00749
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：A749 / A749
页数：1
相关论文
共 11 条
  • [1] The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe postoperative pain
    Lichtor, JL
    Sevarino, FB
    Joshi, GP
    Busch, MA
    Nordbrock, E
    Ginsberg, B
    ANESTHESIA AND ANALGESIA, 1999, 89 (03): : 732 - 738
  • [2] ORAL TRANSMUCOSAL FENTANYL CITRATE (OTFC) FOR THE TREATMENT OF POSTOPERATIVE PAIN
    ASHBURN, MA
    LIND, GH
    GILLIE, MH
    DEBOER, AJF
    PACE, NL
    STANLEY, TH
    ANESTHESIA AND ANALGESIA, 1993, 76 (02): : 377 - 381
  • [3] Oral transmucosal fentanyl citrate (OTFC) compared with IV morphine for acute pain in patients following abdominal surgery
    Sevarino, FB
    Ginsberg, B
    Lichtor, JL
    Joshi, GP
    Nordbrock, E
    Busch, MA
    ANESTHESIA AND ANALGESIA, 1997, 84 : S330 - S330
  • [4] Breakthrough pain. Advances in treatment: oral transmucosal fentanyl citrate
    Jose Bayona-Bauset, Maria
    Honrubia-Gozalvez, Estela
    Luis Villanueva-Perez, Vicente
    Asensio-Samper, Juan
    De Andres-Ibanez, Jose Antonio
    ENFERMERIA CLINICA, 2006, 16 (03): : 155 - 159
  • [5] AN OPEN LABEL STUDY OF ORAL TRANSMUCOSAL FENTANYL CITRATE (OTFC) FOR THE TREATMENT OF BREAKTHROUGH CANCER PAIN
    FINE, PG
    MARCUS, M
    DEBOER, AJ
    VANDEROORD, B
    PAIN, 1991, 45 (02) : 149 - 153
  • [6] Breakthrough cancer pain:: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulfate immediate release (MSIR®)
    Coluzzi, PH
    Schwartzberg, L
    Conroy, JD
    Charapata, S
    Gay, M
    Busch, MA
    Chavez, J
    Ashley, J
    Lebo, D
    McCracken, M
    Portenoy, RK
    PAIN, 2001, 91 (1-2) : 123 - 130
  • [7] Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study
    Portenoy, RK
    Payne, R
    Coluzzi, P
    Raschko, JW
    Lyss, A
    Busch, MA
    Frigerio, V
    Ingham, J
    Loseth, DB
    Nordbrock, E
    Rhiner, M
    PAIN, 1999, 79 (2-3) : 303 - 312
  • [8] Multicenter, double-blind, randomized comparison of oral transmucosal fentanyl citrate (OTFC) vs. placebo in cancer patients with breakthrough pain
    Rauck, R
    Farrar, J
    Homesley, H
    Busch, M
    ANESTHESIOLOGY, 1997, 87 (03) : A748 - A748
  • [9] Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain:: Patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC®, ACTIQ®)
    Taylor, Donald R.
    Webster, Lynn R.
    Chun, Steven Y.
    Reinking, Jeffrey
    Stegman, Mary
    Shoemaker, Steven
    Fortner, Barry
    PAIN MEDICINE, 2007, 8 (03) : 281 - 288
  • [10] A Randomized clinical trial of oral transmucosal fentanyl citrate versus intravenous morphine sulfate for initial control of pain in children with extremity injuries
    Mahar, Patrick J.
    Rana, Jamal A.
    Kennedy, Christopher S.
    Christopher, Norman C.
    PEDIATRIC EMERGENCY CARE, 2007, 23 (08) : 544 - 548
12